Sep 22, 2026 · 1h 37m
Lifestyle may outrun Alzheimer’s drugs
306. The Alzheimer's Drug With a 25% Brain Bleed Risk - Dr. David Perlmutter
The conversation frames Alzheimer’s as a decades-long neurometabolic process, making metabolic health, sleep, exercise, and social connection central to prevention.
- 1Alzheimer’s risk can build decades before symptoms through insulin resistance, inflammation, mitochondrial dysfunction, and impaired microglial function.
- 2Exercise, sleep, plant-forward nutrition, metabolic monitoring, and social connection are presented as practical tools for protecting brain health.
- 3Anti-amyloid drugs offer limited benefits while carrying serious risks including brain swelling, hemorrhage, and death, according to the discussion.
Don't miss
Perlmutter contrasts intensive lifestyle support with anti-amyloid drugs, emphasizing the drugs’ limited benefits alongside risks of brain swelling, hemorrhage, and death.
The brief
Gary Brecka and David Perlmutter argue that Alzheimer’s risk begins long before symptoms, with insulin resistance, inflammation, and metabolic dysfunction accelerating brain aging.
Their neurometabolic model centers on microglia: healthy cells support neurons and the blood-brain barrier, while metabolic stress can push them toward destructive inflammation.
The practical prescription is broad but concrete: exercise, strength and balance work, quality sleep, lower-glycemic plant-forward nutrition, metabolic tracking, and social connection.
The episode’s central tension comes when lifestyle intervention is compared with anti-amyloid drugs, whose limited benefits are weighed against brain swelling, hemorrhage, and death.
Perlmutter also treats genetics as predisposition rather than destiny, while presenting creatine, vitamin D, omega-3s, B vitamins, red light, and mitochondrial therapies with varying levels of evidence.
Books & mentions
Some links are affiliate links — PodLume may earn a commission if you buy.
